About Inserm Transfert
Inserm Transfert is a Financial Services company based in Paris (France) founded in 2000. Investments are directed toward early-stage healthcare companies in France. Inserm Transfert offers products and services including Technology Transfer and Collaborative Funding. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Inserm Transfert was founded in 2000 and is based in Paris, France. Operations are centered on venture capital activities within the healthcare sector. Early-stage companies operating across France are targeted for investments. Assistance is extended to health innovation projects, including those in biotechnology and medical technologies. The firms domain, inserm-transfert.fr, facilitates these investment and transfer initiatives in the French ecosystem.
- Headquarters Paris, France
- SectorsFinancial Services
- Email••••••••
- Phone•••• ••••
- Website inserm-transfert.fr
- Social LinkedIn X YouTube
- Legal Name Inserm Transfert
- Latest Funding Round$216.27K (USD), Grant
Sep 2022
- Investors
Products & Services of Inserm Transfert
Inserm Transfert offers a comprehensive portfolio of products and services, including Technology Transfer and Collaborative Funding.
Technology transfer is conducted to protect and commercialize research outcomes in life sciences, linking fundamental research to clinical applications.
Collaborative funding is provided for projects that involve partnerships with industries and investors to support innovation and societal impact.
Apps and channels of Inserm Transfert
its YouTube channel Inserm has 467K subscribers and 29 videos.
Videos from Inserm Transfert
The most watched videos on Inserm Transfert's YouTube channel, Inserm (467K subscribers). Click a video to play it here.
More on Inserm.
Funding Insights of Inserm Transfert
- Total Rounds 11
- Last Round Grant — $216,272
- Investors Count 1
Latest 10 of 11 funding rounds of Inserm Transfert with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $216,272 | Grant | – | – | – |
| Jun 2021 | $448,065 | Grant | – | – | |
| Mar 2021 | $306,475 | Grant | – | – | |
| Jul 2020 | $312,232 | Grant | – | – | |
| Jan 2020 | Grant | – | – | – | |
| Jan 2019 | $217,675 | Grant | – | – | |
| Jan 2018 | $899,918 | Grant | – | – | |
| Jan 2017 | $370,380 | Grant | – | – | |
| Oct 2016 | $351,000 | Grant | – | – | |
| Feb 2013 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Inserm Transfert
Inserm Transfert has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Inserm Transfert
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Inserm Transfert
3 dated milestones of Inserm Transfert across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Inserm Transfert is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $216K.
Web traffic of Inserm Transfert
The website of Inserm Transfert (inserm-transfert.fr) receives about 2K visits a month.
- Monthly visits2K
▲ 6.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inserm Transfert
Inserm Transfert was founded in 2000 and raised its 1st funding round 11 years after it was founded.
Inserm Transfert is headquartered in Paris, France.
Inserm Transfert was founded in 2000 and is based in Paris, France. Operations are centered on venture capital activities within the healthcare sector. Early-stage companies operating across France are targeted for investments. Assistance is extended to health innovation projects, including those in biotechnology and medical technologies. The firms domain, inserm-transfert.fr, facilitates these investment and transfer initiatives in the French ecosystem.
Inserm Transfert offers Technology Transfer and Collaborative Funding.
Inserm Transfert has 1 investor. Key investors include European Union.
Inserm Transfert operates through Inserm Transfert.